Navigation Links
Clinical Study Published Showing Benefits of Glue Used in Facelift Surgery
Date:9/28/2007

BEVERLY HILLS, Calif., Sept. 28 /PRNewswire/ -- Dr. Davis B. Nguyen, M.D. announced today that his and Dr. Frank M. Kamer, M.D.'s co-authored study on the benefits of the use of fibrin glue adherent in facelift surgery has been published in the September issue of world's premier Plastic and Reconstructive Surgery Journal, that of the American Society of Plastic Surgeons. The study represents the most comprehensive clinical assessment of the use of fibrin glue in facelifts to date and its conclusions demonstrate a significant advancement in surgical facelift technique.

The study was conducted at the venerated Lasky Clinic in Beverly Hills, one of the first accredited outpatient ambulatory surgical centers in greater Los Angeles, founded by Dr. Frank Kamer in 1981. Dr. Nguyen and Dr. Kamer analyzed two hundred patients undergoing elective facelifts in a consistent fashion. One hundred patients over a one year period received fibrin glue during facelift surgery and their healing was measured prospectively. Another one hundred patients from the previous year who had not received fibrin glue had their charts retrospectively reviewed. All patients underwent facelifts by the same surgeon using the deep plane technique, which involves repositioning large skin flaps at multiple levels of the face. Patient healing was evaluated in stages at 24 hours, 48 hours, 1 week, 1 month, and 3 months postoperatively.

The use of fibrin glue was associated with several significant benefits in both the short and long-term healing processes of the patients studied. Fibrin glue alleviated the need for drainage tubes postoperatively that can cause discomfort. The tubes are normally placed under the skin for 1-2 days following facelift surgery to collect blood and prevent swelling. The fibrin glue adherent, which is applied before the external skin flap is resealed, also reduced the incidence of severe complications such as hematoma, seroma, and death. Most notably, zero percent of patients who received fibrin glue suffered prolonged swelling, discoloration, or hardness as opposed to twenty-two percent of patients who had not received fibrin glue.

Fibrin Tissue adhesive dates back to World War I when it was used topically to control the bleeding of wounded soldiers. Since then, it has been utilized with success in a variety of surgical procedures. It has been approved by the US Food and Drug Administration for colostomy procedure, cardiopulmonary bypass, and splenic surgery. Its use in aesthetic surgery, though popular in Europe, has been less widespread in the United States. Dr. Davis Nguyen, former chief surgical resident at Yale University, is among the few facial plastic surgeons employing this advanced facelift technique. "This advancement has had a tremendous impact on my practice," states Nguyen. "The major concerns for my patients are results, risk, and downtime. With this technique, my patients benefit from shorter recovery periods, fewer complications, and superior surgical outcomes."

ABOUT Dr. Davis B. Nguyen -- Dr. Nguyen is dual Board Certified in Facial Plastics and Otolaryngology. He currently practices in Beverly Hills, California where he focuses on the specialty of facial plastic and reconstructive surgery. He graduated from the University of California (UCLA), Summa Cum Laude, attended medical school at The University of Rochester as a Whipple Scholarship recipient, completed a research fellowship in General Surgery at Harvard Medical School, and conducted his surgical residency at Yale University. He is an instructor at the USC School of Medicine and has presented several papers at both national and international surgical conferences. For more information visit http://www.drdavisnguyen.com

Contact:

Jessica Inserra

310.550.0288

jessicainserra@hotmail.com


'/>"/>
SOURCE Dr. Davis B. Nguyen, M.D.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. How do patients benefit of clinical trials
2. Magnetic resonance angiography in clinical medicine
3. Clinical trials need to be more frank
4. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
5. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
6. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
7. Clinical Comparisons Between ADHD Drugs Are Less
8. Outsourcing clinical trials to India
9. Erectile dysfunction: an early warning sign of clinically silent coronary artery disease?
10. India to maintain Public domain Registry database of clinical trials conducted in India.
11. A Novel System For Clinical Banking Of Umbilical Cord Blood
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)... ... January 21, 2017 , ... Pacifica Graduate Institute’s Alumni Association ... of events for its annual meeting “Coming Home 2017,” an activity-packed weekend of ... 2017” will be held on Friday January 27 through Sunday, January 29, 2017 ...
(Date:1/21/2017)... ... , ... In the United States, 20 million women and 10 million men ... feel shame for having struggled with an eating disorder as well as common co-occurring ... in Life After an Eating Disorder” -- to be featured at this year’s iaedp ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it ... to couches to dressers and bicycles. Roadie — the national on-the-way delivery network — ... center through February 28th. , “January is an exciting time when resolutions are ...
(Date:1/20/2017)... Boca Raton, FL (PRWEB) , ... January 20, 2017 , ... ... supplement development, announced it attended the January ECRM trade show to continue the marketing ... technologically advanced vitamin C supplement, known for providing 400 percent better absorption than traditional ...
(Date:1/20/2017)... , ... January 20, 2017 , ... ... products to enhance people’s everyday lives, recently attended the January ECRM Trade Show ... ATP Science is known for its large range of supplements that keep the ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... Avillion LLP, a co-developer and financier of late-stage pharmaceutical product candidates, ... Chief Medical Officer. Dr Weinberg will be based in ... ... 17 years as a pharmaceutical and biotech executive with experience ranging ... of his career, he has interfaced with the US Food & ...
(Date:1/19/2017)... -- Report Details What can be expected ... to grow at the fastest rates? This visiongain report ... opportunities and prospects. Our 190-page report provides 124 ... in the industry and the future market prospects. Our ... all the major categories of the ophthalmic devices market. ...
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast to ... ) today announced it will release results for the fourth quarter ... ... host a conference call at 4:30 PM ET on Wednesday, February ... full year 2016 financial results and other corporate activities. To participate ...
Breaking Medicine Technology: